Previous post Next post

Novartis begins construction of new research centre in San Diego, US

The Swiss pharma company Novartis has begun work on a new global biomedical research centre in San Diego, United States. The 43,300 m2 facility will be operational in 2029 and house around 1,000 employees. +Get the most important news from Switzerland in your inbox The new centre is a key pillar of the pharmaceutical group's planned $23 billion (CHF19 billion) investment in the US. The facility is designed to accelerate the discovery of breakthrough drugs and will become an integral part of Novartis's global research network, which includes sites in Basel, Switzerland, and Cambridge, Massachusetts, the company giant said. + Novartis announces billion-dollar investment in US Researchers will focus on key therapeutic fields such as neuroscience, oncology, age-related diseases and regenerative medicine, exploiting state-of-the-art technology platforms. "This new research centre will strengthen our scientific leadership and accelerate drug discovery for patients around the world," said ... Full story here Are you the author?
About Swissinfo
Swissinfo
SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC). Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.
Previous post See more for 3.) Swissinfo Business and Economy Next post
Tags: ,

Permanent link to this article: https://snbchf.com/2026/02/novartis-construction-new-research-centre-san-diego/

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This site uses Akismet to reduce spam. Learn how your comment data is processed.